BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 32203398)

  • 21. Frontotemporal dementia and primary progressive aphasia: an update.
    Kirshner HS
    Curr Neurol Neurosci Rep; 2010 Nov; 10(6):504-11. PubMed ID: 20717853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies.
    Gazzina S; Manes MA; Padovani A; Borroni B
    Eur J Pharmacol; 2017 Dec; 817():76-85. PubMed ID: 28579383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.
    Guven G; Lohmann E; Bras J; Gibbs JR; Gurvit H; Bilgic B; Hanagasi H; Rizzu P; Heutink P; Emre M; Erginel-Unaltuna N; Just W; Hardy J; Singleton A; Guerreiro R
    PLoS One; 2016; 11(9):e0162592. PubMed ID: 27632209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic signatures of genetic frontotemporal dementia.
    Rohrer JD; Warren JD
    Curr Opin Neurol; 2011 Dec; 24(6):542-9. PubMed ID: 21986680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing perspectives on frontotemporal dementia: A review.
    Snowden JS
    J Neuropsychol; 2023 Jun; 17(2):211-234. PubMed ID: 36315040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
    Nolan M; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
    Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse models of frontotemporal dementia.
    Roberson ED
    Ann Neurol; 2012 Dec; 72(6):837-49. PubMed ID: 23280835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Haukedal H; Freude K
    J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
    Neumann M
    Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo PET imaging of neuroinflammation in familial frontotemporal dementia.
    Malpetti M; Rittman T; Jones PS; Cope TE; Passamonti L; Bevan-Jones WR; Patterson K; Fryer TD; Hong YT; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):319-322. PubMed ID: 33122395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is frontotemporal dementia?
    Kurz A; Kurz C; Ellis K; Lautenschlager NT
    Maturitas; 2014 Oct; 79(2):216-9. PubMed ID: 25059437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Frontotemporal Dementia Prevention Initiative: Linking Together Genetic Frontotemporal Dementia Cohort Studies.
    Rohrer JD; Boxer AL
    Adv Exp Med Biol; 2021; 1281():113-121. PubMed ID: 33433872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA-binding proteins with prion-like domains in health and disease.
    Harrison AF; Shorter J
    Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ALS and frontotemporal dementia - case report and review of the literature].
    Nass RD; Meister IG; Haupt WF; Fink GR
    Fortschr Neurol Psychiatr; 2012 Dec; 80(12):711-9. PubMed ID: 23229103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CBI-R detects early behavioural impairment in genetic frontotemporal dementia.
    Nelson A; Russell LL; Peakman G; Convery RS; Bouzigues A; Greaves CV; Bocchetta M; Cash DM; van Swieten JC; Jiskoot L; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD;
    Ann Clin Transl Neurol; 2022 May; 9(5):644-658. PubMed ID: 35950369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
    EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the treatment and management of frontotemporal dementia.
    Benussi A; Borroni B
    Expert Rev Neurother; 2023; 23(7):621-639. PubMed ID: 37357688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.